GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Conduit Pharmaceuticals Inc (FRA:ZK7) » Definitions » Cash From Other Investing Activities

Conduit Pharmaceuticals (FRA:ZK7) Cash From Other Investing Activities : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Conduit Pharmaceuticals Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Conduit Pharmaceuticals's cash from other investing activities for the three months ended in Sep. 2024 was €0.00 Mil. It means Conduit Pharmaceuticals received €0.00 Mil from other investing activities. Conduit Pharmaceuticals's cash from other investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.


Conduit Pharmaceuticals Cash From Other Investing Activities Historical Data

The historical data trend for Conduit Pharmaceuticals's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conduit Pharmaceuticals Cash From Other Investing Activities Chart

Conduit Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23
Cash From Other Investing Activities
- -0.31 0.21

Conduit Pharmaceuticals Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Conduit Pharmaceuticals Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conduit Pharmaceuticals Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Conduit Pharmaceuticals's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Conduit Pharmaceuticals Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
4995 Murphy Canyon Road, Suite 300, San Diega, CA, USA, 92123
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Conduit Pharmaceuticals Headlines

No Headlines